Drug Shortage Report for CEFAZOLIN FOR INJECTION

Last updated on 2020-10-08 History
Report ID 122696
Drug Identification Number 02108135
Brand name CEFAZOLIN FOR INJECTION
Common or Proper name CEFAZOLIN SODIUM INJ
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEFAZOLIN
Strength(s) 10G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-20
Estimated end date 2020-10-31
Actual end date 2020-10-07
Shortage status Resolved
Updated date 2020-10-08
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-10-08 French Compare
v6 2020-10-08 English Compare
v5 2020-10-01 French Compare
v4 2020-10-01 English Compare
v3 2020-08-21 English Compare
v2 2020-08-20 French Compare
v1 2020-08-20 English Compare